Neutrophil gelatinase-associated lipocalin (NGAL) and cystatin C: potential biomarkers for early prediction of acute kidney injury in pediatric male patients
DOI:
https://doi.org/10.69923/IJAS.2024.010103Keywords:
Acute Kidney Injury (AKI) , Neutrophil gelatinase-associated lipocalin (NGAL) , Cystatin CAbstract
AKI is a common severe condition, Kidneys are affected by AKI due to the circumstances of death, such as trauma or anoxia, or complications of subsequent treatment. AKI can progress to chronic Kidney disease (CKD). To prevent progression, this study aims to estimate the relationship between NGAL and cystatin C and other parameters in AKI patients. The study was to detect the level of serum markers in AKI patients in Kerbala City. 120 pediatric male samples were divided into two groups of 90 patients and 30 healthy controls matched for age and sex. The serum NGAL and Cystatin C levels. Kidney function tests ( Creatinine and Urea, BUN, GFR, Electrolytes, and Urine output), and Biochemical tests (CRP and Albumin) were measured the mean of age in (AKI) patients (5.94±4.93) with controls (7.70±5.02). A highly significant difference increased NGAL between patients (5.69±1.23) and controls (2.30±0.28) and Cystatin C between patients (12.50±2.88) and controls (5.32±1.71) at P≤0.01. The study showed higher serum NGAL and Cystatin C and related to early predicting renal complication. High levels of (serum Creatinine, serum Urea, CRP, Chloride (Cl), and BUN) in AKI and lower each of (glomerular filtration rate GFR, K, Albumin, and Urine output).
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Iraqi Journal for Applied Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licenses and Copyright
The copyright of this article is retained by the author(s).
This article is published by the Iraqi Journal for Applied Science (IJAS) under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license permits unrestricted use, distribution, reproduction, adaptation, and reuse of the work in any medium or format, including commercial use, provided that appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any modifications are indicated.
Authors retain full copyright of their work and grant IJAS a non-exclusive license to publish, archive, preserve, and disseminate the article, including registration of metadata and Digital Object Identifiers (DOIs) through Crossref.
Any third-party material included in this article remains subject to its respective copyright and licensing conditions. Authors are responsible for obtaining all necessary permissions for such material before publication.
For complete details regarding copyright, licensing, permissions, and reuse, please refer to the journal's Copyright and Licensing Policy available on the IJAS website.
License: https://creativecommons.org/licenses/by/4.0/



